en
Professional article
English

Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia

Published inEuropean Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 9, p. 1470-1486
Publication date2018
Abstract

FDG-PET is frequently used as a marker of synaptic damage to diagnose dementing neurodegenerative disorders. We aimed to adapt the items of evidence quality to FDG-PET diagnostic studies, and assess the evidence available in current literature to assist Delphi decisions for European recommendations for clinical use.

Keywords
  • Dementia/diagnostic imaging
  • Fluorodeoxyglucose F18
  • Humans
  • Positron-Emission Tomography
  • Sensitivity and Specificity
Citation (ISO format)
BOCCARDI, Marina et al. Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia. In: European Journal of Nuclear Medicine and Molecular Imaging, 2018, vol. 45, n° 9, p. 1470–1486. doi: 10.1007/s00259-018-4024-1
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1619-7070
366views
0downloads

Technical informations

Creation01/04/2019 4:23:00 PM
First validation01/04/2019 4:23:00 PM
Update time03/15/2023 3:43:06 PM
Status update03/15/2023 3:43:05 PM
Last indexation01/17/2024 4:51:40 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack